Chevallier, P., Thiebaut, A., François, S., Chantepie, S., Rubio, M.-T., Labussiere-Wallet, H., Brissot, E., Maillard, N., Huynh, A., Coiteux, V., Jullien, M., Garnier, A., Le Bourgeois, A., Peterlin, P. and Guillaume, T. (2025) “A phase II study of ponatinib for prevention of relapse after allogeneic transplantation in FLT3 internal tandem duplication mutation-positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial”, Haematologica. Pavia, Italy, 110(10), pp. 2525-2529. doi: 10.3324/haematol.2025.287681.